Medicxi Launches Alys Pharmaceuticals in $100m Seed Funding by Mark Eisenberg 19.02.2024 Medicxi launches Alys Pharmaceuticals with $100m funding to develop groundbreaking therapies in immunodermatology. The company aims to address unmet needs ...